Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
Clinical trial NCT05192304 · UNKNOWN
Trial details
- NCT number
- NCT05192304
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-03-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.